Analysed SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) News Sources
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
18-05-2026
yahoo.com
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
29-07-2026
yahoo.com
Silexion Therapeutics Reports New Positive Preclinical Findings Demonstrating Multi-Mechanism Immune Sensitization by SIL204 in KRAS-Driven Cancers
04-08-2026
yahoo.com
Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
14-08-2026
yahoo.com
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
09-09-2026
yahoo.com
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
28-09-2026
yahoo.com
What is the current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is $0.1746.
SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is $-0.01425.
SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is -7.5457%.
What is the most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The most recent sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is .
SEC-8K** Filing Available For SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.